Citius Oncology, Inc. CTOR Other Expenses
Other Expenses at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherExpenses.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s other expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s other expenses?
- Citius Oncology, Inc. (CTOR) reported other expenses of $27.94K in Q1 2026.
- How has Citius Oncology, Inc.'s other expenses changed year-over-year?
- Citius Oncology, Inc.'s other expenses decreased by 8.0% year-over-year, from $30.37K to $27.94K.
- What is the long-term trend for Citius Oncology, Inc.'s other expenses?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s other expenses has grown at a -2.0% compound annual growth rate (CAGR), from $121.47K to $116.61K.
- What does other expenses mean?
- Captures incidental or non-recurring operational costs that are not classified within standard expense categories like R&D or G&A. Monitoring this helps identify hidden overhead or unusual operational outflows.